Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Long-term cardiovascular … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients.

Artikel i vetenskaplig tidskrift
Författare Gudmundur Johannsson
B A Bengtsson
Bert Andersson
J Isgaard
Kenneth Caidahl
Publicerad i Clinical endocrinology
Volym 45
Nummer/häfte 3
Sidor 305-14
ISSN 0300-0664
Publiceringsår 1996
Publicerad vid Hjärt-kärlinstitutionen
Institutionen för invärtesmedicin
Sidor 305-14
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Adult, Blood Pressure, drug effects, Cardiovascular System, drug effects, physiopathology, Cross-Over Studies, Double-Blind Method, Echocardiography, Doppler, Exercise Test, Follow-Up Studies, Growth Disorders, drug therapy, physiopathology, Growth Hormone, deficiency, therapeutic use, Heart Rate, drug effects, Humans, Male, Recombinant Proteins, therapeutic use, Stroke Volume, drug effects, Time Factors
Ämneskategorier Endokrinologi, Kardiovaskulär medicin, Klinisk fysiologi

Sammanfattning

The long-term cardiovascular effects of GH administration in adults are of major clinical importance, given the increasing use of such treatment. We have evaluated long-term cardiovascular effects of recombinant human GH (rhGH) substitution in GH deficient men.S.c. rhGH 0.5 U/kg/week or placebo was administered in a 6-month double-blind, cross-over study, followed (after a year without substitution) by a 42-month period of open GH substitution.We evaluated 7 GH-deficient men serially and compared the results with 21 men matched in terms of age and height.Investigations included exercise tests and Doppler-echocardiography to determine exercise capacity and cardiovascular performance.Heart rate and systolic blood pressure at rest increased with GH substitution to the level of the controls, as did diastolic blood pressure after an initial reduction. Age-adjusted exercise capacity increased during the study and we found no evidence of ischaemic heart disease on exercise ECG. Stroke volume increased with GH substitution, thereby normalizing the initially reduced cardiac index. There was no significant change in left atrial or ventricular internal dimensions, systolic function as measured by fractional shortening, or diastolic function as measured by isovolumic relaxation time and left ventricular filling (A/E ratio). However, a lower atrial emptying index than that seen among controls might indicate some diastolic disturbance and there was a definite increase in left ventricular wall thickness compared with controls (to 25.1 +/- 1.5 vs 19.7 +/- 0.4 mm, P < 0.001).We found that GH substitution in GH-deficient adults had a beneficial effect on physical performance and cardiac output. The concomitant increase in left ventricular mass index might be an effect of an excessive substitution dose.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?